Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.China-Biotics signs contract with Henan Square Pharmaceutical
Jinan Song, chairman and CEO of China-Biotics, said: “Square Pharmaceutical marks our fifth bulk additives customer, all of which have signed contracts before we begin production at our
Jinan Song, chairman and CEO of China-Biotics, said: “Square Pharmaceutical marks our fifth bulk additives customer, all of which have signed contracts before we begin production at our
PolyMedix received a notice of no objection from Health Canada for the company’s clinical trial application for PMX-30063 in May 2008. This first Phase I clinical trial will
The newly released secondary endpoint data extends clinical evidence that intravenous Dyloject offers safe, efficacious and well-tolerated pain relief for abdominal and pelvic surgery, the company said. Patient
Prior to joining the company as corporate controller in May 2008, Mr Henighan was vice president and corporate controller at HemoSense and corporate controller at Cholestech. Ron Bissinger,
The trial will evaluate Adentri, which is being developed under a licensing agreement with CV Therapeutics, or placebo in addition to standard of care in approximately 900 patients
Evexar Medical, in co-operation with University College London, has developed a technology to address endoleaks. The patented Evexar EndoSeal technology effectively seals gaps that can occur between an
The research will focus on the utilization of cord blood and menstrual blood derived cells, known as ECFCs and MenSCs, respectively. ECFCs are cord blood-derived endothelial colony-forming cells.
In Phase IIa, KRP-104 was shown to be well tolerated and efficacious in the treatment of hyperglycemia in patients with type 2 diabetes resulting in highly significant improvements
Somatic Systems said that the new Phoenix location will serve as a dedicated sales office, which will enable low overhead while providing a presence for the company in
Available through the Pirkka Reducol product range – jointly developed by Kesko Food and Scanvit – the processed cheese slices will initially be available in Finland, said Forbes